NCT05520788View on ClinicalTrials.gov

Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Hepatocellular CarcinomaBiliary Tract Cancer
Interventions
GENETIC

precise medicine

During screening stage, all patients should accept next-generation sequencing (NGS) test.

Trial Locations (1)

430030

RECRUITING

Hepatic Surgery Center, Tongji Hospital, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Tongji Hospital

OTHER